DUBLIN, Nov. 1, 2021 /PRNewswire/ — The “Injection Devices for Subcutaneous Self-Administration” report has been added to ResearchAndMarkets.com’s offering.
Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver.
For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.
Injection Devices for Subcutaneous Self-administration- What You Will Learn
Provides detailed analysis of subcutaneous drug products, drug delivery and device…